Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jason A. Holt is active.

Publication


Featured researches published by Jason A. Holt.


Aging Cell | 2016

Lack of evidence for GDF11 as a rejuvenator of aged skeletal muscle satellite cells

Aaron C. Hinken; Janine Powers; Guizhen Luo; Jason A. Holt; Andrew N. Billin; Alan Russell

Recent high‐profile studies report GDF11 to be a key circulating ‘anti‐aging’ factor. However, a screen of extracellular proteins attempting to identify factors with ‘anti‐aging’ phenotypes in aged murine skeletal muscle satellite cells did not identify GDF11 activity. We have been unable to confirm the reported activity of GDF11, similar to other laboratories offering conflicting data and describe our attempts to do so in this short take.


Journal of Medicinal Chemistry | 2010

Structure Guided Design of 5-Arylindazole Glucocorticoid Receptor Agonists and Antagonists

Christopher M. Yates; Peter J. Brown; Eugene L. Stewart; Christopher Patten; Robert J. H. Austin; Jason A. Holt; Jodi M. Maglich; Davina C. Angell; Rosemary Sasse; Simon Taylor; Iain Uings; Ryan P. Trump

Glucocorticoid receptor (GR) agonists have been used for more than half a century as the most effective treatment of acute and chronic inflammatory conditions despite serious side effects that accompany their extended use that include glucose intolerance, muscle wasting, skin thinning, and osteoporosis. As a starting point for the identification of GR ligands with an improved therapeutic index, we wished to discover selective nonsteroidal GR agonists and antagonists with simplified structure compared to known GR ligands to serve as starting points for the optimization of dissociated GR modulators. To do so, we selected multiple chemical series by structure guided docking studies and evaluated GR agonist activity. From these efforts we identified 5-arylindazole compounds that showed moderate binding to the glucocorticoid receptor (GR) with clear opportunities for further development. Structure guided optimization was used to design arrays that led to potent GR agonists and antagonists. Several in vitro and in vivo experiments were utilized to demonstrate that GR agonist 23a (GSK9027) had a profile similar to that of a classical steroidal GR agonist.


British Journal of Pharmacology | 2013

Discovery of GW870086: a potent anti‐inflammatory steroid with a unique pharmacological profile

Iain Uings; Deborah Needham; Joyce Lesley Matthews; Michael V. Haase; R Austin; Davina C. Angell; Karen Leavens; Jason A. Holt; Keith Biggadike; Stuart N. Farrow

Glucocorticoids are highly effective therapies for a range of inflammatory diseases. Advances in the understanding of the diverse molecular mechanisms underpinning glucocorticoid action suggest that anti‐inflammatory molecules with reduced side effect liabilities can be discovered. Here we set out to explore whether modification of the 17α position of the steroid nucleus could generate molecules with a unique pharmacological profile and to determine whether such molecules would retain anti‐inflammatory activity.


ACS Chemical Biology | 2016

Discovery of Novel Small Molecules that Activate Satellite Cell Proliferation and Enhance Repair of Damaged Muscle

Andrew N. Billin; Marcus Bantscheff; Gerard Drewes; Sonja Ghidelli-Disse; Jason A. Holt; Henning F. Kramer; Alan J. McDougal; Terry L. Smalley; Carrow I. Wells; William J. Zuercher; Brad R. Henke

Skeletal muscle progenitor stem cells (referred to as satellite cells) represent the primary pool of stem cells in adult skeletal muscle responsible for the generation of new skeletal muscle in response to injury. Satellite cells derived from aged muscle display a significant reduction in regenerative capacity to form functional muscle. This decrease in functional recovery has been attributed to a decrease in proliferative capacity of satellite cells. Hence, agents that enhance the proliferative abilities of satellite cells may hold promise as therapies for a variety of pathological settings, including repair of injured muscle and age- or disease-associated muscle wasting. Through phenotypic screening of isolated murine satellite cells, we identified a series of 2,4-diaminopyrimidines (e.g., 2) that increased satellite cell proliferation. Importantly, compound 2 was effective in accelerating repair of damaged skeletal muscle in an in vivo mouse model of skeletal muscle injury. While these compounds were originally prepared as c-Jun N-terminal kinase 1 (JNK-1) inhibitors, structure-activity analyses indicated JNK-1 inhibition does not correlate with satellite cell activity. Screening against a broad panel of kinases did not result in identification of an obvious molecular target, so we conducted cell-based proteomics experiments in an attempt to identify the molecular target(s) responsible for the potentiation of the satellite cell proliferation. These data provide the foundation for future efforts to design improved small molecules as potential therapeutics for muscle repair and regeneration.


Genes & Development | 2003

Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis

Jason A. Holt; Guizhen Luo; Andrew N. Billin; John E. Bisi; Y. Yvette McNeill; Karen F. Kozarsky; Mary H. Donahee; Da Yuan Wang; Traci Ann Mansfield; Steven A. Kliewer; Bryan Goodwin; Stacey A. Jones


European Respiratory Journal | 2013

GW870086: A potent anti-inflammatory glucocorticoid with a novel pharmacological profile

Stuart N. Farrow; Iain Uings; Michael V. Haase; Davina C. Angell; Karen Leavens; Jason A. Holt; Joyce Lesley Matthews; Keith Biggadike; Deborah Needham


British Journal of Pharmacology | 2013

Discovery of GW870086;a novel glucocorticoid with a unique pharmacological profile

Iain Uings; Deborah Needham; Joyce Lesley Matthews; Michael V. Haase; R Austin; Davina C. Angell; Karen Leavens; Jason A. Holt; Keith Biggadike; Stuart N. Farrow


Archive | 2010

SPECIAL FEATURE 279 Minireview: The SRC Family of Coactivators: An Entree to Understanding a Subset of Polygenic Diseases?

David M. Lonard; Rakesh Kumar; Bert W. O'malley; Heng-Yu Fan; JoAnne S. Richards; William A. Alaynick; Stephanie A. Wilson; William G. Benson; Liming Pei; Michael A. Downes; Ruth T. Yu; Johan W. Jonker; Jason A. Holt; Deepak K. Rajpal; Hao Li; Joan Stuart; Ruth McPherson; Katja S. Remlinger; Ching-Yi Chang; Donald P. McDonnell; Ronald M. Evans; Andrew N. Billin


Endocrine Reviews | 2009

ERRγ Regulates Cardiac, Gastric, and Renal Potassium Homeostasis

William A. Alaynick; James M. Way; Stephanie A. Wilson; William G. Benson; Liming Pei; Michael Downes; Ruth T. Yu; Johan W. Jonker; Jason A. Holt; Deepak K. Rajpal; Hao Li; Joan Stuart; Ruth McPherson; Katja S. Remlinger; Ching Yi-Chang; Donald P. McDonnell; Ronald M. Evans; Andrew N. Billin


Archive | 2002

Mouse farnesoid x receptor sequences for use in comparative pharmacology

Jason A. Holt; Jodi M. Maglich; John T. Moore

Collaboration


Dive into the Jason A. Holt's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge